ALDH9A1 and neoplasm: Our subcutaneous tumor xenografts studies revealed that the enforced expression of ALDH9A1 remarkably restrained the tumor growth in comparisons with the vector group, whereas the knockdown of IQGAP2 reversed the impact of ALDH9A1 overexpression on the tumor growth (Fig. 8A).